Alivus Life Sciences Limited (GLS)
Market Open
19 Oct, 09:56 AM
MSE MSE Primary XNSE ₹
1,272. 90
-36.25
-2.769%
₹
- Market Cap
- P/E Ratio
- Div Yield
4,897 Volume
- Eps
₹ 1,309.15
Previous Close Want to track GLS and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Alivus Life Sciences Limited (GLS) Statistics
Valuation metrics
Market Cap -
Enterprise value 132.9B
Trailing P/E (ttm) 27.4
Forward P/E -
PEG ratio -4.44
Price/Sales (ttm) 5.57
Price/Book (mrq) 4.74
Enterprise Value/Revenue 5.57
Enterprise Value/EBITDA 19.58
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 3.01K
Average volume (90 days) 11.13K
Price summary
52-Week low 830
52-Week high 1,495.3
Beta -
50-Day moving average 1,374.22
200-Day moving average 1,192.59
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin 0.2%
Operating margin 0.38%
Operational effectiveness
Return on assets 0.14%
Return on equity 0.19%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 194.24
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) 39.52
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 44.65
Total debt (mrq) -
Total Debt/Equity (mrq) 0.02
Current ratio (mrq) 4.97%
Book value per share (mrq) 229.28
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
2026 © Marketlog. All Rights Reserved.
